CompletedPhase 1/2

Effects of 2% IDL Lotion on Skin Hydration and Transepidermal Water Loss in Females With Dry Skin

United States16 participantsStarted 2017-02-13

Plain-language summary

This was a placebo-controlled double-blinded trial to compare effects of 2% IDL lotion to placebo in female subjects with dry skin. Primary endpoints were skin hydration (NovaMeter) and transepidermal water loss (VapoMeter).

Who can participate

Age range35 Years – 57 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Females who were thirty-five to fifty-seven years of age.
✓. Individuals free of any dermatological or systemic disorder, which would have interfered with the results, at the discretion of the investigator.
✓. Individuals who had completed a preliminary medical history mandated by Cantor Research Laboratories, Inc.
✓. Individuals who had read, understood and signed an informed consent document as required by Reference 21 CFR Ch. 1 Part 50, Subpart B. Consent forms are kept on file and are available for examination on the premises of Cantor Research Laboratories, Inc., only.
✓. Individuals who had abstained from the use of all moisturizing products for at least one week prior to treatment conditions.
✓. Individuals with known dry skin.

Exclusion criteria

✕. Individuals who were under doctor's care.
✕. Individuals who were taking medication, which in the opinion of the investigator would have masked or interfered with the results.
✕. Individuals with chronic skin allergies.
✕. Females who were pregnant or lactating.

What they're measuring

Skin Hydration

Timeframe: Days 0, 7, 14 and 18

Transepidermal water loss (TEWL)

Timeframe: Days 0, 14 and 18

Trial details

NCT IDNCT04253704

SponsorShyla Cantor

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2017-03-03

View on ClinicalTrials.gov More Xerosis Cutis trials